NasdaqCM - Nasdaq Real Time Price USD
Oramed Pharmaceuticals Inc. (ORMP)
2.1500
-0.0500
(-2.27%)
At close: May 16 at 4:00:00 PM EDT
2.1100
-0.04
(-1.86%)
After hours: May 16 at 7:59:23 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -- |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.02 | -0.02 | -0.02 | -0.01 |
| EPS Actual | 0.22 | -0.48 | -0.26 | -0.19 |
| Difference | 0.24 | -0.46 | -0.24 | -0.18 |
| Surprise % | 1,200.00% | -2,300.00% | -1,200.00% | -1,800.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ORMP | -- | -- | -- | -- |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral | 9/9/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 5/20/2024 |
| Maintains | Canaccord Genuity: Hold to Hold | 5/17/2023 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 1/17/2023 |
| Downgrade | Canaccord Genuity: Buy to Hold | 1/12/2023 |
| Maintains | Aegis Capital: Buy | 5/16/2022 |
Related Tickers
DRTS Alpha Tau Medical Ltd.
2.7900
-5.74%
SLRN Acelyrin, Inc.
2.2500
+3.69%
ENTX Entera Bio Ltd.
2.0300
0.00%
PPBT Purple Biotech Ltd
2.2700
+1.34%
EVGN Evogene Ltd.
1.3100
+6.50%
MNOV MediciNova, Inc.
1.3200
-5.04%
PLUR Pluri Inc.
5.21
-0.57%
CANF Can-Fite BioPharma Ltd.
1.0500
+0.48%
XTLB XTL Biopharmaceuticals Ltd.
1.1100
-2.63%
SCNI Scinai Immunotherapeutics Ltd.
2.9100
+5.43%